MST Therapy Guide: How Brain Magnets Treat Depression

Magnetic Seizure Therapy (MST) is an investigational treatment that uses focused magnetic pulses to trigger a controlled seizure under general anesthesia. The goal is to relieve severe depression while causing fewer memory side effects than traditional electroconvulsive therapy (ECT). Research centers such as the Icahn School of Medicine at Mount Sinai continue to study MST for patients with treatment-resistant depression.

Watching someone you love struggle with depression that will not respond to medication or talk therapy is frightening. You start to wonder what options are left. Magnetic Seizure Therapy, sometimes described by patients as “brain magnets,” has emerged as one path families explore when standard treatments fall short.

This guide walks through how MST therapy works, how it compares to ECT, and what patients and families should know before considering it.

What Is MST Therapy for Depression?

Magnetic Seizure Therapy uses a focused magnetic field to trigger a brief, controlled seizure in the brain while the patient is under general anesthesia. Doctors believe this seizure activity helps reset dysfunctional neural circuits linked to severe depression.

MST is still considered investigational in the United States. That means it is primarily available through research studies and select academic medical centers, not as a routine outpatient treatment.

How Is MST Different From TMS?

Patients often confuse MST with Transcranial Magnetic Stimulation (TMS), but these treatments work in different ways.

• TMS: Uses repeated magnetic pulses to stimulate specific brain regions without inducing a seizure. It is FDA-approved and typically done without anesthesia in an outpatient setting.
• MST: Intentionally induces a seizure under anesthesia, similar in goal to ECT, but uses magnetic fields instead of electrical currents to reach that threshold.

How Does MST Compare to Electroconvulsive Therapy (ECT)?

ECT has long been one of the most effective treatments for severe, treatment-resistant depression. Still, many patients and families hesitate because of concerns about memory loss and other cognitive side effects.

Researchers at institutions including the Icahn School of Medicine at Mount Sinai have studied MST as a way to preserve the therapeutic seizure activity of ECT while targeting the magnetic field more precisely. This may reduce how much electrical current spreads into memory-related brain regions.

Why Do Cognitive Side Effects Differ?

MST allows clinicians to focus the magnetic field on specific areas of the brain’s surface, largely sparing the deeper structures involved in memory formation. ECT’s electrical current spreads more broadly through brain tissue, which researchers believe contributes to the memory difficulties some patients experience after treatment.

Who Might Be a Candidate for MST Therapy?

MST is generally considered for patients who have not responded to multiple rounds of medication or psychotherapy. Because it remains investigational, access is currently limited to clinical trial sites and specialized research hospitals.

You do not have to figure this out on your own. Your loved one’s psychiatrist can help determine whether a clinical trial is an appropriate next step, and whether other options, including ECT, TMS, or intensive outpatient care, may be more accessible in the meantime.

Finding the Right Support for Treatment-Resistant Depression

Exploring a treatment as advanced as MST can feel overwhelming, especially when you are already exhausted from searching for answers. You do not have to navigate this alone. Our behavioral team offers coordinated psychiatric care and understands every option available, from medication management to advanced interventions like MST. Reach out to us today by calling us at +1-718-367-2555 or walking into our clinic at 1797 Pitkin Avenue, Brooklyn, NY 11212 to talk through the next step for your loved one’s care.